Skip to main content
. 2016 Mar 3;7(3):e2130. doi: 10.1038/cddis.2016.26

Figure 6.

Figure 6

LINC01225 as a biomarker for HCC diagnosis and prognosis. (a) Kaplan–Meier analysis was initiated to discover whether the expression of LINC01225 was associated with overall survival of HCC patients. The median was used as the cutoff. (b) Expression of LINC01225 was detected in patients from whom plasma was obtained preoperatively, by comparison with patients free of tumor. Receiver operating characteristic curve analysis of LINC01225 was used to detect the diagnostic efficiency of HCC.